MS21
MS21 is a novel PROTAC that targets AKT for degradation, selectively inhibiting the growth of cancers with mutations in the PI3K/PTEN pathway while sparing those with wild-type KRAS and BRAF.
-
Catalog:
BP-42238
-
Name:
MS21
-
Formula:
C58H79ClN12O6S
-
MW:
1107.9
-
CAS:
2376137-05-0
-
Purity:
-
Ships Within:
24 Hours
-
Storage Condition:
-20°C
-
Shipping:
Ambient Temperature
-
NMR:
View
-
SDS:
Inquire about MSDS